Navigation Links
Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product
Date:7/7/2008

- Company to Engage Contract Sales Organization And Seek New Marketing

Partner to Promote Product in UK -

LAVAL, QC, July 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has reacquired the sales and marketing rights to its once-daily tramadol product (Tradorec XL(R)) for the United Kingdom from Recordati Ireland Ltd. (Recordati). To promote its product in the UK, the Company will engage a contract sales organization and pursue a new licensing and distribution agreement with an appropriate marketing partner.

"Our once-daily tramadol product is achieving strong market penetration, particularly in Spain, Italy and Canada, and we believe that this success can be replicated in the UK with the appropriate sales and marketing effort behind Tradorec XL(R)," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "The market for tramadol products in the UK continues to exhibit strong growth and we are confident in both our product and its prospects in this market."

Under its agreement with Recordati to reacquire the UK rights to its once-daily tramadol product, Labopharm will continue to use the brand name Tradorec XL(R) in marketing its product. Labopharm will also receive a (euro)700,000 milestone from Recordati upon termination of Recordati's rights.

Labopharm is in discussions to finalize an agreement with a contract sales organization to promote Tradorec XL(R) in the UK. The Company is also in discussions to establish a licensing and distribution agreement with a new marketing partner.

The UK is the second largest European market for tramadol products (on a standard units basis) and one of the fastest growing of the five largest European markets for tramadol products (on a standard units basis). The UK tramadol market has experienced compound annual growth of 18% over the last five 12-month periods ended March 30.

About Labopharm In
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 On Tuesday, July 9, Eric ... VA office joined CBS affiliate WUSA’s Andrea Roane ... the audience about the number of ways Shady Grove ... motherhood possible for women after they undergo cancer ... patients in the developing field known as oncofertility which ...
(Date:7/11/2014)... Beach, CA (PRWEB) July 11, 2014 ... pure Artichoke Leaf Extract dietary supplements to aid in ... an action necessary to facilitate metabolism of fat. Formulated ... Superior Labs Artichoke Leaf Extract is available in all-natural, ... pure artichoke extract. , Health Benefits of Artichoke ...
(Date:7/11/2014)... July 11, 2014 This morning(July 9th, 2014 ... Morning Memphis to discuss the illegal immigration crisis at our ... of McAllen, Texas. , Dr. Flinn told Good Morning Memphis ... absolutely wide open… The problem is that they do not ... of people per day are coming into the border; the ...
(Date:7/11/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of ... the children from other nations, who are trying to escape ... President Barack Obama is fighting to let these children get ... wants to help him. , “It is really heartbreaking ... Salvador being treated as if they are doing something wrong ...
(Date:7/11/2014)... Minneapolis, MN (PRWEB) July 11, 2014 ... now offering complimentary perineplasty for each qualifying patient ... Steven Shu has been performing laser vaginal rejuvenation, ... over three years. The LVR procedure decreases the ... effectively enhances vaginal muscle tone, strength, and control, ...
Breaking Medicine News(10 mins):Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Senate Candidate, George Flinn on Fox13 NEWS About the Border Crisis 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3
... major limitation of endoscopic ultrasound (EUS) examination is ... of a lesion. The differential diagnosis between benign ... based on the EUS appearance is difficult and ... confirmation of malignancy. Elastography has recently been presented ...
... of hepatitis C (HCV) infection with type II mixed ... A research article to be published on April 7, ... addresses this question. The research team led by Professor ... People,s Liberation Army 161 Hospital in Wuhan used IgH ...
... Calgary, AB- The most disabling aspect of Tourette syndrome ... conjunction with another disorder. The most frequent co-occurring ... disorder (ADHD), though the cause of this association is ... but having two means coping with more than twice ...
... , , WEDNESDAY, April 15 (HealthDay News) -- If you have ... or pop in a CD of mellow songs. , Hospital ... rate and blood pressure just by listening to music, a ... report, published in the latest issue of The Cochrane ...
... Their children are prone to risky behaviors, study finds , , ... away at war, their teenage children are more likely to ... grades at school, a new study has found. , But ... during the deployment tended to fare better. , "Adolescents are ...
... Inc. ("Rib-X" or the "Company"), a development-stage company focused ... the treatment of antibiotic-resistant infections, today announced the issuance ... State Intellectual Property Office of the People,s Republic of ... 0021883.9 to Rib-X. This patent provides composition of ...
Cached Medicine News:Health News:Can EUS elastography help distinguish benign from malignant tissue? 2Health News:Do patients at risk for B-cell malignancy need antiviral treatment? 2Health News:Tourette syndrome misconceptions only one battle for patients 2Health News:Soothing Songs Please the Heart 2Health News:Deployment Takes Toll on Military Moms and Teens 2Health News:Deployment Takes Toll on Military Moms and Teens 3Health News:Rib-X Granted Key Antibiotic Patent in China 2
(Date:7/10/2014)... Calif. , July 10, 2014 Integrated ... leader in advanced memory and analog IC solutions, today ... on Thursday, July 24, 2014, at 7:00 a.m. Pacific ... financial results for the fiscal 2014 third quarter ended ... call via telephone, dial 1-888-556-4997 before 6:50 a.m. Pacific ...
(Date:7/10/2014)... July 10, 2014   Ventana Medical Systems, Inc. ... it has entered into an agreement with Merck KGaA, ... EMD Serono in the United States ... with Merck KGaA,s biopharmaceutical division on the development and ... target using Ventana,s proprietary diagnostic assays. In alignment with ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... IRIDEX Corporation (Nasdaq: IRIX ) today reported ... Revenues were $10.8 million, gross margins were 45.4% ... of 2011 compared to guidance of $10 million, 45%, and ... the third quarter of 2011 and 7% in the nine ...
... an increased need by customers for support and education ... chain-wide effort to increase its pharmacy expertise in the ... diabetes specialists, announced Effie Steele, clinical services manager for ... community pharmacist is an important first line of defense ...
Cached Medicine Technology:IRIDEX Reports 2011 Third Quarter and Nine-Month Results 2IRIDEX Reports 2011 Third Quarter and Nine-Month Results 3IRIDEX Reports 2011 Third Quarter and Nine-Month Results 4IRIDEX Reports 2011 Third Quarter and Nine-Month Results 5Meijer Launches Diabetes Education Initiative in All 197 Pharmacies, Trains More Than 200 Pharmacists to Be Diabetes Specialists 2Meijer Launches Diabetes Education Initiative in All 197 Pharmacies, Trains More Than 200 Pharmacists to Be Diabetes Specialists 3
Dome shape, extra smooth tip provides safe insertion through wound & manipulation within the eye. 45, 4.0mm from end...
...
...
...
Medicine Products: